CSat Investment Advisory’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-221
| Closed | -$18K | – | 858 |
|
|
2020
Q3 | $18K | Buy |
221
+28
| +15% | +$2.28K | ﹤0.01% | 900 |
|
|
2020
Q2 | $15K | Sell |
193
-203
| -51% | -$15.8K | ﹤0.01% | 925 |
|
|
2020
Q1 | $18K | Buy |
396
+70
| +21% | +$3.18K | ﹤0.01% | 748 |
|
|
2019
Q4 | $14K | Sell |
326
-1,865
| -85% | -$80.1K | ﹤0.01% | 894 |
|
|
2019
Q3 | $94K | Buy |
2,191
+390
| +22% | +$16.7K | 0.03% | 332 |
|
|
2019
Q2 | $114K | Buy |
+1,801
| New | +$114K | 0.04% | 276 |
|